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Purpose. To report the first successful endovascular repair of a non-aneurysmal aortic rupture due to periaortic tumour
regression.
Case Report. A 58-year-old man developed spontaneous infrarenal aortic rupture following chemotherapy which led to
regression of a periaortic mesothelioma that had been diagnosed during explorative laparotomy 11 months earlier.
Stent-graft placement was performed with intentional conversion of a bifurcated (Zenith, COOK) into an aorto-uni-iliac
system. No complications were encountered during a 40 months follow-up.
Conclusion. Endovascular repair should be considered as a treatment option in non-aneurysmal aortic rupture.
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Atraumatic, noninfectious rupture of a nonaneurys-
mal infrarenal aorta is exceptionally rare. Seventeen
cases have been reported of spontaneous rupture of
a nonaneurysmal infrarenal aorta believed attribut-
able to penetrating aortic ulcers.1 To our knowledge,
aortic rupture due to regression of a periaortic tumour
has not yet been described. Aortic rupture requires
immediate surgery. Stent-graft repair has recently
become an alternative treatment to open surgery for
aortic aneurysm rupture.2,3 The present case report
demonstrates successful endovascular treatment of in-
frarenal aortic rupture after chemotherapy of a mesen-
chymal periaortic tumour.
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A 58-year-old man had been readmitted to the depart-
ment of internal medicine to receive further chemo-
therapy treatment for a peritoneal mesothelioma.
This tumour had been diagnosed during explorative
laparotomy 11 months earlier (Fig. 1). Following the
fourth cycle of a second chemotherapy series, the
patient developed severe leukopenia, temperatures
of up to 40 C, and flank pain due to staphylococcus
sepsis which required treatment in the intensive care
unit. A CT exam was performed to search for a focus
of infection and led to the detection of spontaneous
infrarenal aortic rupture (Fig. 2A) most probably
due to regression of the periaortic tumour. Neither
at the initial explorative laparotomy nor during the
follow-up was there any evidence of infrarenal aortic
enlargement or aneurysm formation. The patient’s
blood pressure was low but stable. Under emergency
conditions EVAR was undertaken immediately.
The only available stent-graft system (Zenith, TFB-
3-24, COOK Europe, Bjaerskov, Denmark) was larger
than ideally required. As a result, intraoperative occlu-
sion of the left iliac artery occurred, thus convertingrved.
303Stent-graft for Aortic RuptureFig. 1. Axial computed tomography (CT) three months
before aortic rupture demonstrating laterodorsal periaortic
tumor manifestation of mesothelioma.the originally bifurcated stent-graft system function-
ally into an aorto-monoiliac system (Fig. 2C,D). Hence
separate occlusion of the left iliac artery was not
necessary. To revascularize the left lower extremity,
a silver-impregnated cross-femoral bypass graft was
chosen prophylactically to protect against graft infec-
tion. Another consequence of strongly oversizing the
stent-graft was that the aortic diameter increased up
to the stent-graft diameter at follow-up (Fig. 2B,C).
On the first postoperative day, CT-guided biopsy of
the periaortic fluid collection was performed, reveal-
ing hematoma but no abscess formation. Post-
operatively, there was an immediate drop in body
temperature to normal values. Severe neutropenia and
sepsis were successfully treated using G-CSF (Filgas-
tim) and antibiotics (initially Piperacillin-tazobactam
and then Cefazolin/Vancomycin according to anti-
biotic sensitivities). Because the margin of retroperito-
neal hematoma showed contrast enhancement on CTFig. 2. CT scans after aortic rupture and during follow-up after stent-graft repair using a bifurcated system (Zenith, TFB-3-
24, COOK Europe, Bjaerskov, Denmark). (A) Axial CT demonstrating infrarenal aortic rupture cranial to the aortic bifur-
cation. (B) Axial view one week after EVAR. (C) Axial view 19 months postoperatively. The aortic diameter has gradually
increased up to the real diameter (24 mm) of the more than usually oversized graft. (D) Three-dimensional CT reconstruc-
tion showing the functionally aorto-monoiliac stent-graft without pathological findings and the patent cross-femoral graft
25 months after EVAR.Eur J Vasc Endovasc Surg Vol 33, March 2007
304 R. I. Ru¨ckert et al.Table 1. Stent-graft repair of penetrating ulcer of the infrarenal abdominal aorta
Author/Year Number Rupture Stent-graft system Follow-up (months)
Eggebrecht4/2001 1 e Talent (Medtronic) 6
Tsuji5/2003 4 2 Gianturco Z-Stent (COOK)þDacron graft
(UBE woven graft, Ube Inc.)
32/7/11/4
Vasquez6/2003 1 1 Talent (Medtronic) 6
Batt1/2003 3 e Talent (Medtronic, bifurcated)þHemobahn (Gore) 41
Zenith (COOK, bifurcated) 26
Zenith (COOK, aortomonoiliac) 12on the 7th postoperative day CT-guided biopsy was
repeated, now demonstrating coagulase-negative
staphylocci. Long-term antibiotic therapy with Cipro-
floxacin was initiated. The patient made an unevent-
ful recovery and was discharged on the 15th
postoperative day. At present, 51 months after diagno-
sis of retroperitoneal mesothelioma, there is no suspi-
cion of residual or recurrent disease. The stent-graft
has dilated the infrarenal aorta up to its nominal
diameter of 24 mm and the cross-femoral bypass graft
is patent (Fig. 2D). Follow-up is being continued every
six months.
Discussion
Although the most frequent cause of aortic rupture is
aneurysm there are other potential causes such as
trauma or plaque rupture. Non-traumatic, non-infectious
rupture of the non-aneurysmal infrarenal aorta is rare
and most frequently caused by penetrating atheroscle-
rotic ulcer.1 Nine cases could be identified in the liter-
ature in which EVAR had been performed to treat
infrarenal penetrating aortic ulcer (Table 1).
Infrarenal aortic rupture due to tumour erosion is
extremely rare. For primary aortic tumours, rupture
has been described only in a single case of leiomyosar-
coma of the thoracic aorta.7 Spontaneous rupture of
the non-aneurysmal infrarenal aorta has been re-
ported with tumour infiltration in neurofibromatosis.8
All reported cases of primary malignant lymphoma
invading the infrarenal aorta were associated with
symptomatic or ruptured aortic aneurysms. EVAR
was successfully performed in one such case.9 Rup-
ture of the infrarenal aorta due to either erosion of
the aortic wall or periaortic tumor regression after
successful chemotherapy has not been reported to
date. The development of an aortic pseudoaneurysm
after chemotherapy of a germ cell tumour was de-
scribed.10 Therefore, the present case is most probably
the first report of successful EVAR for spontaneous
aortic rupture after chemotherapy of a periaortic
peritoneal mesothelioma. Furthermore, the present
case is the fourth report to date of EVAR to treatEur J Vasc Endovasc Surg Vol 33, March 2007non-aneurysmal infrarenal aortic rupture. All three
cases reported earlier were caused by penetrating
ulcer (Table 1).
On the other hand, aortic rupture due to focal aor-
tic infection can not be ruled out completely because
CT-guided biopsy on the 7th postoperative day re-
vealed infected periaortic haematoma. However, the
same investigation on the first postoperative day did
not prove infection. Thus, the periaortic haematoma
might also have become infected during leukopenia
postoperatively.
In the case reported here two treatment options
were available. We felt that open surgery had some
major drawbacks due to the need for re-laparotomy,
the poor general condition of the patient and the po-
tential for infection of the operation field. Minimally
invasive EVAR was deemed to offer advantages
with respect to all potential disadvantages of conven-
tional aortic repair. EVAR seems to be safer than con-
ventional grafting in a potentially infected operating
field.11,12 Because of severe leukopenia, a minimally
invasive procedure was strongly recommended.
Hinchliffe et al. reported the successful use of EVAR
to treat a ruptured pseudoaneurysm of the infrarenal
aorta secondary to pancreatitis.13 However, in case of
infection EVAR may only represent an interim mea-
sure prior to conventional repair because of persistent
infection and potential progressive aortic necrosis.
In conclusion, after 40 months, in the case pre-
sented EVAR has proven to be a successful treatment
of non-traumatic rupture of the non-aneurysmal
infrarenal aorta. However, long-term follow-up,
particularly concerning tumour staging, is required.
EVAR should become an established treatment option
of aortic rupture.
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